Guanfacine Extended Release and Mindfulness Skills Therapy
NCT03258476 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL
Last updated 2021-03-08
Summary
Teenagers are invited to take part voluntarily in a research study of a study drug known as guanfacine extended release (Intuniv™) and a type of psychotherapy called Mindfulness Skills Training which teaches people how to focus on the present moment in a nonjudgmental manner to help them cope with their stresses and worries. Teenagers are being asked to take part in this study if they have had traumatic stress related over arousal symptoms. He/she may also have difficulties with worries, anxiety, temper, aggression, quick mood changes, behavior problems, and/or difficulties with symptoms of Attention Deficit Hyperactivity Disorder (ADHD) including inattention, hyperactivity, and impulsivity with or without Posttraumatic Stress Disorder (PTSD); and is not responding adequately to his/her current treatment.
The primary purpose of the teenager's participation in this study is to help answer the following research question(s), and not to provide treatment for his or her condition:
* To investigate if Intuniv™ helps for the symptoms of traumatic stress and emotional and behavioral overarousal in children with a history of traumatic developmental stress with and without PTSD.
* To investigate if Intuniv™ helps your teenager engage with and benefit from Mindfulness Skills Training therapy
* To better understand how Intuniv™ works in the brain.
* To investigate how well your child tolerates Intuniv™ during the study.
Conditions
- Stress Disorder
Interventions
- DRUG
-
Guanfacine Extended Release
Intuniv (guanfacine) is a prescription medicine used to treat attention deficit hyperactivity disorder (ADHD) in children who are at least 6 years old. An open-label trail of guanfacine extended release (GXR 1-4 mg/daily; Intuniv™) suggested benefits in improving behavioral and emotional regulation in children and adolescents with symptoms of traumatic stress. However, to date no controlled clinical trial has been completed assessing the effects of GXR on traumatic stress symptoms in youths
- BEHAVIORAL
-
Mindfulness Skills Therapy
Mindfulness is a therapy for anxiety and stress. Mindfulness forms of therapy involve regulation of attention, maintaining it in immediate experience, regardless of the valence and desirability of the experience. To reduce anxiety, Mindfulness encourages observing and accepting anxiety-related thoughts
- DRUG
-
Placebo oral capsule
Sponsors & Collaborators
-
Shire
collaborator INDUSTRY -
Yale University
collaborator OTHER -
UConn Health
lead OTHER
Principal Investigators
-
Asima F Zehgeer, MD · UConn Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 10 Years
- Max Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-01
- Primary Completion
- 2019-12-03
- Completion
- 2019-12-03
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl
NCT01081132 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Guanfacine Extended-Release on Attention Deficit Hyperactivity Disorder (ADHD)-Associated Insomnia
NCT01156051 ·Status: TERMINATED ·Phase: PHASE4
-
Neurobiological Basis of Response to Guanfacine Extended Release in Children and Adolescents With ADHD
NCT01709695 ·Status: COMPLETED ·Phase: PHASE4
-
Electrophysiological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder (ADHD)
NCT01069523 ·Status: COMPLETED ·Phase: PHASE4
-
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine for Tourette Syndrome and Attention Deficit Hyperactivity Disorder
NCT00004376 ·Status: COMPLETED ·Phase: PHASE3
-
Treating Young Children With Attention Deficit Hyperactivity Disorder
NCT07300956 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Single Versus Combination Medication Treatment for Children With Attention Deficit Hyperactivity Disorder
NCT00429273 ·Status: COMPLETED ·Phase: PHASE4
-
Extended-release Guanfacine Hydrochloride in Children/Adolescents With Attention-deficit/Hyperactivity
NCT03662763 ·Status: COMPLETED ·Phase: PHASE3
-
Mindfulness-Based ADHD Treatment for Children: a Feasibility Study
NCT04737512 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Drug Use Study With Intuniv® in European Countries
NCT05870605 ·Status: COMPLETED
-
Methylphenidate in Children and Adolescents With Pervasive Developmental Disorders
NCT00025779 ·Status: COMPLETED ·Phase: NA
-
Guanfacine for Hyperactivity in Children With Down Syndrome (HYPEbeGONE_DS)
NCT06042257 ·Status: TERMINATED ·Phase: PHASE2
-
Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome
NCT05657860 ·Status: COMPLETED ·Phase: PHASE4
-
CLONICEL (Clonidine Sustained Release) as Add-on to Stimulant Medication in 6 to 17 Yr-olds With ADHD
NCT00641329 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Ketamine and Guanfacine on Working Memory in Healthy Subjects
NCT01600885 ·Status: COMPLETED ·Phase: NA
-
Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)
NCT01081145 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Safety and Efficacy of CLONICEL® to Treat Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
NCT00556959 ·Status: COMPLETED ·Phase: PHASE3
-
Mindful Awareness Practices for ADHD Pilot Open Trial
NCT05584475 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Methylphenidate HCl ER Capsules in Children and Adolescents With ADHD
NCT01239030 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of GXR as Adjunctive Therapy With Psycho-stimulant on Executive Function in Children With ADHD
NCT01985581 ·Status: COMPLETED ·Phase: PHASE4
-
A Double-Blind Comparison of Concerta and Placebo in Adults With Attention Deficit Hyperactivity Disorder
NCT00181571 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity Disorder
NCT00326391 ·Status: COMPLETED ·Phase: PHASE3
-
Skills Training for Adolescents With ADHD
NCT01019252 ·Status: COMPLETED ·Phase: NA
-
An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD
NCT02259517 ·Status: TERMINATED ·Phase: NA
-
A 6-week Study to Evaluate the Safety and Efficacy of Quillichew ERCT in 4-5 Year Old Children With ADHD.
NCT03580005 ·Status: WITHDRAWN ·Phase: PHASE4